Last updated: March 21, 2024
Sponsor: Azienda Usl di Bologna
Overall Status: Active - Recruiting
Phase
N/A
Condition
Spinal Stenosis
Spondylolisthesis
Treatment
decompression and instrumented fusion
microsurgical decompression
Clinical Study ID
NCT06335511
631-2021-OSS-AUSLBO
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- degenerative lumbar stenosis caused by bone hypertrophy, osteoarthritis of facetjoints, ligamentous hypertrophy, disc protrusion
- midsagittal spinal canal diameter of 12 mm or less
- no radiological signs of instability, i.e. pathological motion on preoperative dynamiclumbar X-ray
- ongoing symptoms for a minimum of 12 weeks with no improvement to conservativetreatment
- eligibility for decompression alone (MiD) or decompression and fusion (MiD+F)
Exclusion
Exclusion Criteria:
- congenital, traumatic, infectious and neoplastic lumbar stenosis,
- spondylolisthesis (on static X-ray), lumbar scoliosis (Cobb>10°),
- previous lumbar surgery, other types of operations (endoscopic decompression, anteriorinterbody fusions, interspinous devices etc.).
- patients with spine deformity requiring long fusion (i.e. >=3 levels)
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: decompression and instrumented fusion
Phase:
Study Start date:
October 10, 2022
Estimated Completion Date:
February 28, 2025
Study Description
Connect with a study center
IRCCS Istituto Ortopedico Rizzolo
Bologna, 40136
ItalyActive - Recruiting
IRCCS Istituto delle Scienze Neurologiche di Bologna
Bologna, 40139
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.